• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外血液净化(CytoSorb®)成功降低横纹肌溶解症患者肌酸激酶和肌红蛋白水平。

Successful Reduction of Creatine Kinase and Myoglobin Levels in Severe Rhabdomyolysis Using Extracorporeal Blood Purification (CytoSorb®).

机构信息

Department of Intensive Care, Erasmus Medical Centre, University Medical Center, Rotterdam, The Netherlands,

Department of Intensive Care, Erasmus Medical Centre, University Medical Center, Rotterdam, The Netherlands.

出版信息

Blood Purif. 2020;49(6):743-747. doi: 10.1159/000505899. Epub 2020 Feb 28.

DOI:10.1159/000505899
PMID:32114569
Abstract

Rhabdomyolysis, if severe, can lead to acute kidney injury (AKI). Myoglobin is an iron and oxygen-binding protein that is freely filtered by the glomerulus. Precipitation of myoglobin in the nephrons' distal parts is responsible for tubular damage with AKI as a consequence. Extracorporeal clearance of myoglobin is conventionally attempted by the use of continuous renal replacement therapy (CRRT) with high cut-off dialysis membranes to limit the extent of the damage. We describe a case of a 56-year-old man with traumatic crush injury and a persistent source of muscle ischaemia unresponsive to high dose CRRT with EMiC-2 filter. Due to therapy failure, he was subsequently treated with the addition of a haemoadsorber (CytoSorb®) to the circuit. This reduced myoglobin and creatine kinase levels successfully despite ongoing tissue ischaemia. However, CytoSorb® was not enough to maintain microcirculatory perfusion, resulting in the eventual demise of the patient due to severity of the injury. Our report indicates that myoglobin was efficiently removed with CytoSorb® following exchange with the conventional high cut-off filter in continuous venovenous haemodialysis in severe traumatic rhabdomyolysis.

摘要

横纹肌溶解症如果严重,可导致急性肾损伤 (AKI)。肌红蛋白是一种含铁和氧的蛋白质,可自由地被肾小球过滤。肌红蛋白在肾单位远端的沉淀导致肾小管损伤,从而导致 AKI。传统上,通过使用高通量透析膜的连续肾脏替代治疗 (CRRT) 来清除肌红蛋白,以限制损伤的程度。我们描述了一例 56 岁男性,因创伤性挤压伤导致持续的肌肉缺血,对高剂量 CRRT 联合 EMiC-2 过滤器治疗无反应。由于治疗失败,随后在回路中添加了血液吸附剂 (CytoSorb®)。尽管持续存在组织缺血,但这成功降低了肌红蛋白和肌酸激酶水平。然而,CytoSorb® 不足以维持微循环灌注,最终由于损伤的严重程度导致患者死亡。我们的报告表明,在严重创伤性横纹肌溶解症的连续静脉-静脉血液透析中,与传统的高通量过滤器进行交换后,CytoSorb® 可有效地清除肌红蛋白。

相似文献

1
Successful Reduction of Creatine Kinase and Myoglobin Levels in Severe Rhabdomyolysis Using Extracorporeal Blood Purification (CytoSorb®).体外血液净化(CytoSorb®)成功降低横纹肌溶解症患者肌酸激酶和肌红蛋白水平。
Blood Purif. 2020;49(6):743-747. doi: 10.1159/000505899. Epub 2020 Feb 28.
2
Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis.血液净化用细胞因子吸附剂清除危重症横纹肌溶解症患者肌红蛋白。
Crit Care. 2021 Jan 28;25(1):41. doi: 10.1186/s13054-021-03468-x.
3
Case Report: Prevention of Rhabdomyolysis-Associated Acute Kidney Injury by Extracorporeal Blood Purification With Cytosorb.病例报告:使用Cytosorb进行体外血液净化预防横纹肌溶解相关急性肾损伤
Front Pediatr. 2022 Jan 24;9:801807. doi: 10.3389/fped.2021.801807. eCollection 2021.
4
Rapid and Effective Elimination of Myoglobin with CytoSorb® Hemoadsorber in Patients with Severe Rhabdomyolysis.细胞吸附剂 CytoSorb® 快速有效清除横纹肌溶解症患者肌红蛋白。
Blood Purif. 2024;53(2):88-95. doi: 10.1159/000534479. Epub 2023 Nov 2.
5
Cytosorb for Management of Acute Kidney Injury due to Rhabdomyolysis in a Child.细胞吸附剂治疗儿童横纹肌溶解症所致急性肾损伤。
Indian Pediatr. 2019 Nov 15;56(11):974-976.
6
Continuous renal replacement therapy (CRRT) for rhabdomyolysis.用于横纹肌溶解症的连续性肾脏替代治疗(CRRT)
Cochrane Database Syst Rev. 2014 Jun 15;2014(6):CD008566. doi: 10.1002/14651858.CD008566.pub2.
7
Rapid fall in blood myoglobin in massive rhabdomyolysis and acute renal failure.大面积横纹肌溶解症和急性肾衰竭时血肌红蛋白迅速下降。
Intensive Care Med. 1994;20(2):109-12. doi: 10.1007/BF01707664.
8
Use of myoglobin as a marker and predictor in myoglobinuric acute kidney injury.肌红蛋白在肌红蛋白尿性急性肾损伤中作为标志物和预测指标的应用。
Ther Apher Dial. 2013 Aug;17(4):391-5. doi: 10.1111/1744-9987.12084.
9
Rhabdomyolysis: a 10-year retrospective study of patients treated in a medical department.横纹肌溶解症:10 年内科治疗患者的回顾性研究。
Eur J Emerg Med. 2019 Jun;26(3):199-204. doi: 10.1097/MEJ.0000000000000510.
10
Rhabdomyolysis with myoglobin-induced acute kidney injury: A case series of four cases.横纹肌溶解症伴肌红蛋白诱导的急性肾损伤:四例病例系列
Indian J Pathol Microbiol. 2021 Apr-Jun;64(2):382-384. doi: 10.4103/IJPM.IJPM_89_20.

引用本文的文献

1
Dual concomitant CytoSorb hemoadsorption therapy in severe rhabdomyolysis: A novel approach to myoglobin clearance and organ preservation.双重同步CytoSorb血液吸附疗法治疗严重横纹肌溶解症:一种清除肌红蛋白和保护器官的新方法。
Int J Artif Organs. 2025 Jun;48(6):429-433. doi: 10.1177/03913988251339080. Epub 2025 May 16.
2
Extracorporeal myoglobin elimination using the adsorber CytoSorb or the high-flux HF80 dialyzer for patients with severe rhabdomyolysis: a comparative study.使用吸附器CytoSorb或高通量HF80透析器对严重横纹肌溶解症患者进行体外肌红蛋白清除:一项比较研究。
Clin Kidney J. 2025 May 1;18(5):sfaf071. doi: 10.1093/ckj/sfaf071. eCollection 2025 May.
3
Fulminant Red Yeast Rice-Associated Rhabdomyolysis with Acute Liver Injury and Hyperkalemia Treated with Extracorporeal Blood Purification Using CytoSorb.
应用CytoSorb进行体外血液净化治疗暴发性红曲米相关横纹肌溶解症伴急性肝损伤和高钾血症
Drug Healthc Patient Saf. 2025 Apr 18;17:109-120. doi: 10.2147/DHPS.S519861. eCollection 2025.
4
Efficacy of haemoadsorption combined with continuous renal replacement therapy in patients with rhabdomyolysis and acute kidney injury: a retrospective study.血液吸附联合连续性肾脏替代疗法治疗横纹肌溶解症合并急性肾损伤患者的疗效:一项回顾性研究
Clin Kidney J. 2024 Dec 17;18(2):sfae406. doi: 10.1093/ckj/sfae406. eCollection 2025 Feb.
5
Use of Hemoadsorption and Continuous Venovenous Hemodialysis With Enhanced Middle Molecule Clearance in Drug-Induced Rhabdomyolysis.血液吸附联合持续静脉-静脉血液透析用于增强药物性横纹肌溶解症中分子清除的应用
Case Rep Crit Care. 2025 Jan 20;2025:3968057. doi: 10.1155/crcc/3968057. eCollection 2025.
6
Rescue RM/CS-AKI by blocking strategy with one-dose anti-myoglobin RabMAb.通过单剂量抗肌红蛋白兔单克隆抗体阻断策略挽救肾损伤分子-1/胱抑素C急性肾损伤
Nat Commun. 2025 Jan 26;16(1):1044. doi: 10.1038/s41467-025-56353-4.
7
Kidney REPLACEment therapies in patients with acute kidney injury and RHABDOmyolysis (ReplaceRhabdo): a pilot trial.急性肾损伤合并横纹肌溶解患者的肾脏替代治疗(ReplaceRhabdo):一项试点试验。
BMC Nephrol. 2025 Jan 14;26(1):23. doi: 10.1186/s12882-025-03945-3.
8
Endothelial Protection and Improved Micro- and Macrocirculation with Hemoadsorption in Critically Ill Patients.危重症患者血液吸附的内皮保护及改善微循环和大循环作用
J Clin Med. 2024 Nov 22;13(23):7044. doi: 10.3390/jcm13237044.
9
Rare skin color changes in an acute pancreatitis patient undergoing maintenance hemodialysis.维持性血液透析的急性胰腺炎患者罕见的皮肤颜色改变。
BMC Nephrol. 2024 Sep 3;25(1):287. doi: 10.1186/s12882-024-03738-0.
10
Hemoadsorption therapy for myoglobin removal in rhabdomyolysis: consensus of the hemoadsorption in rhabdomyolysis task force.用于横纹肌溶解症中清除肌红蛋白的血液吸附疗法:横纹肌溶解症血液吸附工作组共识
BMC Nephrol. 2024 Jul 31;25(1):247. doi: 10.1186/s12882-024-03679-8.